ACHIEVEMENT OF LDL-C GOALS IN PATIENTS AT MODERATE TO VERY HIGH CARDIOVASCULAR RISK ON LIPID-LOWERING DRUG THERAPY (CEPHEUS II)

被引：1
|
作者：
Logunova, Natalia [1 ]
Gurina, Natalia [1 ]
Boytsov, Sergey [2 ]
机构：
[1] AstraZeneca, Dept Med, Moscow, Russia
[2] Minist Hlth, State Res Ctr Prevent Med, Moscow, Russia
来源：
ATHEROSCLEROSIS | 2017年 / 263卷
关键词：
D O I：
10.1016/j.atherosclerosis.2017.06.770
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO417
引用
收藏
页码：E236 / E237
页数：2
相关论文
共 50 条
  • [21] Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design
    Boulmpou, Aristi
    Kartas, Anastasios
    Farmakis, Ioannis
    Zafeiropoulos, Stefanos
    Nevras, Vasileios
    Papadimitriou, Ioannis
    Tampaki, Athina
    Vlachou, Anastasia
    Lillis, Leonidas
    Koutsakis, Athanasios
    Karvounis, Haralampos
    Giannakoulas, George
    HELLENIC JOURNAL OF CARDIOLOGY, 2019, 60 (04) : 249 - 253
  • [22] Case report: Coronary atherosclerosis in a patient with long-standing very low LDL-C without lipid-lowering therapy
    Mottola, Giorgio
    Welty, Francine K.
    Mojibian, Hamid R.
    Faridi, Kamil F.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [23] LDL-c-linked SNPs are associated with LDL-c and myocardial infarction despite lipid-lowering therapy in patients with established vascular disease
    van de Woestijne, Anton P.
    van der Graaf, Yolanda
    de Bakker, Paul I. W.
    Asselbergs, Folkert W.
    de Borst, Gert Jan
    Algra, Ale
    Spiering, Wilko
    Visseren, Frank L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (02) : 184 - 191
  • [24] Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study
    van de Borne, Philippe
    Peeters, Andre
    Janssens, Luc
    Leone, Attilio
    Lemmens, Robin
    Verhaegen, Ann
    De Meulemeester, Marc
    Balthazar, Yohan
    Heijmans, Stephane
    Calozet, Yvan
    Paquot, Nicolas
    Carlier, Stephane
    Hemelsoet, Dimitri
    Bray, Sarah
    Ray, Kausik K.
    ACTA CARDIOLOGICA, 2024, 79 (01) : 20 - 29
  • [25] The Effectiveness of Outpatient and Hospital Lipid-lowering Therapy in Patients with High and Very High Cardiovascular Risk during 2011-2015
    Smetnev, Stepan A.
    Ershova, Alexandra I.
    Bogdanova, Radmila S.
    Meshkov, Alexey N.
    Boytsov, Sergey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (06) : 622 - 630
  • [26] CORRELATION OF NON-HDL-C AND LDL-C WITH APOB DURING LIPID-LOWERING THERAPY IN PATIENTS WITH COMBINED HYPERLIPIDEMIA (HL)
    Grundy, S.
    Vega, G.
    Tomassini, J.
    Tershakovec, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [27] LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A VERY HIGH CARDIOVASCULAR RISK COHORT OF STATIN INTOLERANT PATIENTS MANAGED BY GENERAL PRACTITIONERS IN ITALY
    Gazzi, L.
    Fanelli, F.
    Heiman, F.
    Di Filippo, A.
    Pegoraro, V
    VALUE IN HEALTH, 2018, 21 : S96 - S96
  • [28] THE EFFECT OF AN INTENSIVE LIPID-LOWERING THERAPY PROTOCOL ON ACHIEVING TARGET LDL-C LEVELS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Seiyama, Kosuke
    Oka, Akihiro
    Takagi, Wataru
    Okada, Tomoaki
    Nosaka, Kazumasa
    Miyoshi, Toru
    Doi, Masayuki
    ATHEROSCLEROSIS, 2024, 395
  • [29] Superior Benefit of Aggressive Lipid-Lowering Therapy for High-Risk Patients Using Statins: the SUBARU Study - More Hypercholesterolemic Patients Achieve Japan Atherosclerosis Society LDL-C Goals with Rosuvastatin Therapy than with Atorvastatin Therapy
    Kurabayashi, Masahiko
    Yamazaki, Tsutornu
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (06) : 314 - 323
  • [30] Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
    Zhang, Shuang
    Li, Zhi-Fan
    Shi, Hui-Wei
    Zhang, Wen-Jia
    Sui, Yong-Gang
    Li, Jian-Jun
    Dou, Ke-Fei
    Qian, Jie
    Wu, Na-Qiong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345